|
|
|
|
|
18.09.25 - 14:03
|
atai Life Sciences Awarded Grant from the National Institutes of Health (GlobeNewswire EN)
|
|
5-year UG3/UH3 grant will fund the optimization and early-stage development of atai's novel 5-HT2A/2C receptor agonists with non-hallucinogenic potential for opioid use disorder 5-year UG3/UH3 grant will fund the optimization and early-stage development of atai's novel 5-HT2A/2C receptor agonists with non-hallucinogenic potential for opioid use disorder...
|
|
|
28.08.25 - 22:09
|
atai Life Sciences to Participate in September Investor Conferences (GlobeNewswire EN)
|
|
NEW YORK and AMSTERDAM, Aug. 28, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, today announced that its management is scheduled to participate in upcoming September investor conferences....
|
|
|
18.08.25 - 17:30
|
Here′s Why atai Life Sciences (ATAI) Is a Great ′Buy the Bottom′ Stock Now (Zacks)
|
|
atai Life Sciences (ATAI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term....
|
|
|
|
|
|
|
|
|
|
|
|
|